Sharp-Header

Sharp-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Approved Endocrinology Drugs in Clinical Development in CHINA

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

BeiGene

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Food & Nutrition Conference & Expo

Participation Not Confirmed

Update your Virtual Booth

Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in C...

Lead Product(s): Denosumab

Therapeutic Area: Endocrinology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Large molecule

Partner/Sponsor/Collaborator: Amgen Inc

Deal Size: $2,800.0 million Upfront Cash: $2,800.0 million

Deal Type: Collaboration January 02, 2020

Details:

The stratagic collabora